Antimicrobial Agents Practice Questions

Q: All are features of ethambutol toxicity, except?

Hypercalcemia. **Explanation:** Ethambutol is a first-line bacteriostatic antitubercular drug that acts by inhibiting the enzyme **arabinosyl transferase**, thereby interfering with cell wall synthesis. **Why Hypercalcemia is the correct answer:** Ethambutol is not associated with calcium metabolism. Hypercalcemia is not a side effect of any standard first-line antitubercular drug. In the context of tuberculosis, hypercalcemia is usually a result of the disease process itself (granulomatous inflammation where activated macrophages convert Vitamin D to its active form, calcitriol), rather than the treatment. **Analysis of incorrect options:** * **Retrobulbar Neuritis (Option A):** This is the most characteristic dose-dependent toxicity of Ethambutol. It typically presents as decreased visual acuity. * **Colour Vision Defects (Option B):** Early toxicity often manifests as an inability to distinguish between red and green (red-green color blindness). This is why baseline and periodic ophthalmological examinations are mandatory. * **Hyperuricemia (Option C):** Ethambutol interferes with the renal excretion of uric acid, which can lead to gouty arthritis. This side effect is shared with Pyrazinamide. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Ethambutol:** "E" for **E**ye (Optic neuritis) and **E**xcretion of Uric acid (decreased). * **Safe in Pregnancy:** Ethambutol is considered the safest first-line ATD during pregnancy. * **Renal Adjustment:** It is primarily excreted by the kidneys; therefore, the dose must be adjusted in patients with renal failure. * **Pediatric Use:** Generally avoided in children below 6 years because visual acuity and color vision are difficult to monitor accurately in this age group.

Q: Orange coloured urine is a known side effect of which of the following drugs?

Rifampicin. **Explanation:** **Rifampicin** is the correct answer because it is a highly lipid-soluble macrocyclic antibiotic that undergoes extensive distribution in the body [1]. It is excreted through various body fluids, including urine, sweat, tears, and saliva. Due to its inherent chemical structure (a naphthoquinonic chromophore), it imparts a characteristic **bright orange-red discoloration** to these secretions [2]. **Why the other options are incorrect:** * **Isoniazid (INH):** Its most significant side effects are peripheral neuropathy (prevented by Pyridoxine/Vitamin B6) and hepatotoxicity [1]. It does not cause pigment changes in urine. * **Pyrazinamide:** The most common side effects are hyperuricemia (which can precipitate gout) and hepatotoxicity. * **Ethambutol:** This drug is notorious for causing **optic neuritis**, leading to decreased visual acuity and red-green color blindness. It does not affect urine color. **Clinical Pearls for NEET-PG:** 1. **Patient Counseling:** Patients starting Rifampicin must be warned about orange urine/tears to prevent unnecessary panic and to avoid permanent staining of soft contact lenses [2]. 2. **Mechanism of Action:** Rifampicin inhibits DNA-dependent RNA polymerase [1]. 3. **Enzyme Induction:** Rifampicin is a potent **microsomal enzyme inducer** (CYP450), leading to numerous drug interactions (e.g., reducing the efficacy of oral contraceptives and warfarin). 4. **Mnemonic:** Remember the "4 R's" for Rifampicin: **R**NA polymerase inhibitor, **R**evs up microsomal enzymes, **R**ed-orange secretions, and **R**esistance develops if used alone.

Q: What drug is used in the treatment of resistant gonorrhea?

Spectinomycin. **Explanation:** The correct answer is **Spectinomycin**. **1. Why Spectinomycin is correct:** Spectinomycin is an aminocyclitol antibiotic (chemically related to aminoglycosides) that inhibits protein synthesis by binding to the 30S ribosomal subunit. It is specifically indicated as an alternative treatment for **resistant gonorrhea**, particularly in patients who are allergic to cephalosporins or in cases where *Neisseria gonorrhoeae* is resistant to first-line agents like Ceftriaxone. It is administered as a single intramuscular injection. **2. Why the other options are incorrect:** * **Penicillin:** Once the gold standard, it is no longer used due to the widespread prevalence of **PPNG (Penicillinase-producing *Neisseria gonorrhoeae*)** strains. * **Cotrimoxazole:** This sulfonamide-trimethoprim combination is ineffective against *N. gonorrhoeae* due to high levels of intrinsic and acquired resistance. * **Erythromycin:** While used for *Chlamydia* in pregnancy, it has poor efficacy against *N. gonorrhoeae* and is not recommended for resistant cases. **3. NEET-PG High-Yield Pearls:** * **Current DOC:** The current first-line treatment for uncomplicated gonorrhea is a single dose of **Ceftriaxone (IM)** plus **Azithromycin (Oral)** to cover potential co-infection with *Chlamydia*. * **Spectinomycin Limitation:** It is **ineffective against pharyngeal gonorrhea** and does not treat syphilis or chlamydial infections. * **Mechanism:** Unlike aminoglycosides, spectinomycin is **bacteriostatic** and does not cause significant ototoxicity or nephrotoxicity.

Q: Anterior nares is the most common site of colonization in the carrier state of MRSA. What is the best treatment?

Topical mupirocin. The anterior nares serve as the primary reservoir for *Staphylococcus aureus*, including Methicillin-resistant *S. aureus* (MRSA) [1]. To eradicate the carrier state and prevent the spread of infection (especially in healthcare workers or pre-operative patients), a localized, high-concentration treatment is required. **Mupirocin (Pseudomonic acid A)** is the drug of choice for this purpose [2]. It works by inhibiting **isoleucyl-tRNA synthetase**, thereby halting bacterial protein synthesis. Its topical application ensures high local concentrations that effectively clear the colonization without systemic side effects. **2. Why the Other Options are Incorrect:** * **Oral Vancomycin:** Vancomycin is not absorbed from the GI tract [1]. It is used orally only for *Clostridioides difficile* colitis. For systemic MRSA, it must be given IV [1]. It is not used for nasal decolonization. * **Inhaled Colistin:** This is used for treating multi-drug resistant Gram-negative infections (like *Pseudomonas*) in cystic fibrosis or ventilator-associated pneumonia, not for Gram-positive nasal colonization [2]. * **IV Cefazolin:** Cefazolin is a first-generation cephalosporin. By definition, **MRSA is resistant to all beta-lactams** (except 5th generation cephalosporins like Ceftaroline) due to the altered penicillin-binding protein (PBP2a).

Q: Sulfonamides inhibit bacterial synthesis of folic acid by:

Competitive inhibition.. **Explanation:** **1. Why Competitive Inhibition is Correct:** Sulfonamides are structural analogs of **Para-Aminobenzoic Acid (PABA)** [1], [2], [3]. In the bacterial folic acid synthesis pathway, the enzyme **Dihydropteroate Synthase** normally utilizes PABA to produce dihydrofolic acid [2]. Because sulfonamides closely resemble PABA, they compete for the same active site on the enzyme [1], [2]. This is a classic example of **competitive inhibition**, which can be reversed by increasing the concentration of the substrate (PABA). Since bacteria must synthesize their own folic acid (unlike humans who absorb it from diet), this inhibition leads to "thymineless death" of the bacteria [1], [3]. **2. Why Other Options are Incorrect:** * **Uncompetitive Inhibition:** The inhibitor binds only to the enzyme-substrate (ES) complex, not the free enzyme. Sulfonamides bind to the free enzyme. * **Allosteric/Non-competitive Inhibition:** These involve binding to a site other than the active site (allosteric site), causing a conformational change. Sulfonamides specifically target the active site where PABA binds [1], [2]. **3. NEET-PG Clinical Pearls & High-Yield Facts:** * **Synergy:** Sulfonamides are often combined with **Trimethoprim** (e.g., Co-trimoxazole) to achieve **sequential blockade** [1], [2], [3]. Trimethoprim inhibits the next step in the pathway: *Dihydrofolate Reductase (DHFR)* [1], [3]. * **Selectivity:** Humans are unaffected because we lack dihydropteroate synthase and utilize preformed folic acid via active transport [3]. * **Resistance:** Bacteria develop resistance by increasing PABA production or altering the enzyme's affinity [3]. * **Adverse Effects:** Watch for **Stevens-Johnson Syndrome (SJS)**, Kernicterus in newborns, and Crystalluria (prevented by alkalinizing urine).

Q: All of the following drugs are contraindicated in patients with G-6-PD deficiency, except?

Ceftriaxone. The core concept behind this question is **Oxidative Stress**. Patients with Glucose-6-Phosphate Dehydrogenase (G-6-PD) deficiency cannot maintain adequate levels of reduced glutathione, which is essential for protecting Red Blood Cells (RBCs) from oxidative damage. When exposed to certain oxidizing drugs, hemoglobin denatures into **Heinz bodies**, leading to acute hemolysis [1]. **Why Ceftriaxone is the correct answer:** Ceftriaxone is a third-generation cephalosporin. Unlike sulfonamides or nitrofurans, cephalosporins do not possess significant oxidizing potential and do not interfere with the pentose phosphate pathway. Therefore, they are safe to use in G-6-PD deficient patients. **Analysis of Incorrect Options:** * **Cotrimoxazole (Sulfamethoxazole + Trimethoprim):** Sulfonamides are classic oxidizing agents and are among the most common triggers for hemolytic anemia in G-6-PD deficiency. * **Furazolidone:** This belongs to the nitrofuran class (like Nitrofurantoin). These drugs undergo redox cycling, generating free radicals that overwhelm the RBC's limited antioxidant capacity. * **Nalidixic acid:** This older quinolone is a known oxidative stressor. While newer fluoroquinolones (like Ciprofloxacin) have a lower risk, Nalidixic acid is strictly contraindicated. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for G-6-PD Triggers:** "**AAA**" – **A**ntimalarials (Primaquine, Chloroquine), **A**ntibiotics (Sulfonamides, Nitrofurantoin, Nalidixic acid), and **A**spirin (high doses) [1]. * **Other notable triggers:** Dapsone (highest risk), Rasburicase, and Fava beans (Favism). * **Peripheral Smear Findings:** Look for **"Bite cells"** (degmacytes) and **Heinz bodies** (visualized with supra-vital stains like Crystal Violet).

Q: Which of the following cephalosporins can cause thrombocytopenia?

Ceftriaxone. **Explanation:** **Ceftriaxone** is a third-generation cephalosporin widely used for its broad-spectrum activity and long half-life. While cephalosporins are generally associated with immune-mediated hemolytic anemia, **Ceftriaxone** is specifically linked to **immune-mediated thrombocytopenia**. This occurs via a drug-induced antibody mechanism where the drug (or its metabolite) binds to platelets, leading to their peripheral destruction. Additionally, Ceftriaxone is unique for causing "biliary sludge" or pseudolithiasis due to its high biliary excretion. **Analysis of Incorrect Options:** * **Cefazolin (Option A):** A first-generation cephalosporin primarily used for surgical prophylaxis. While it can rarely cause leukopenia, it is not the classic answer for drug-induced thrombocytopenia in this context. * **Cefamandole (Option B):** A second-generation cephalosporin known for its **N-methylthiotetrazole (NMTT) side chain**. This side chain causes hypoprothrombinemia (bleeding due to Vitamin K inhibition) and Disulfiram-like reactions, rather than direct thrombocytopenia. * **Ceftobiprole (Option D):** A fifth-generation cephalosporin with activity against MRSA. Its side effect profile focuses more on gastrointestinal upset and dysgeusia (taste disturbance). **High-Yield Clinical Pearls for NEET-PG:** * **NMTT Side Chain Drugs:** Cefamandole, Cefotetan, and Cefoperazone. Remember the mnemonic: *"Man, Tan, Operazone"* for bleeding risks and Disulfiram reactions. * **Ceftriaxone Contraindication:** Avoid in neonates receiving intravenous Calcium (e.g., Calcium Gluconate) due to the risk of fatal **Ceftriaxone-Calcium precipitates** in lungs and kidneys. * **Excretion:** Most cephalosporins are renally excreted; however, **Ceftriaxone and Cefoperazone** are primarily excreted in the bile and do not require dose adjustment in renal failure.

Q: If a drug is active against the pre-erythrocytic stage of the malaria parasite, it will be useful as:

Causal prophylactic. ### Explanation To answer this question, it is essential to correlate the life cycle of the malaria parasite with the clinical terminology of antimalarial therapy. **1. Why "Causal Prophylactic" is correct:** The **pre-erythrocytic stage** (primary hepatic stage) occurs after a mosquito bite but *before* the parasite enters the red blood cells. Drugs that act at this stage prevent the parasite from ever reaching the bloodstream. Therefore, they prevent the initiation of the infection entirely. This is termed **Causal Prophylaxis**. * *Example:* **Primaquine** and **Atovaquone** act as causal prophylactics. **2. Why the other options are incorrect:** * **Suppressive Prophylactic:** These drugs act on the **erythrocytic (RBC) stage**. They do not prevent the liver infection but kill the parasites as they emerge into the blood, thereby "suppressing" clinical symptoms. (e.g., Chloroquine, Mefloquine). * **Clinical Curative:** These drugs are used to treat an established infection by targeting the **erythrocytic stage** to terminate a clinical attack of malaria. (e.g., Artemisinins, Quinine). * **Radical Curative:** This refers to the eradication of **hypnozoites** (latent liver stages) of *P. vivax* and *P. ovale* to prevent a relapse. While this is a liver stage, it is "exo-erythrocytic" rather than "pre-erythrocytic." (e.g., Primaquine, Tafenoquine). ### NEET-PG High-Yield Pearls: * **Primaquine** is the "all-rounder": It acts as a causal prophylactic, a radical curative, and a gametocidal agent. * **Proguanil** is a slow-acting causal prophylactic. * **Pyrimethamine** is a sporontocidal agent (prevents development in the mosquito). * **True Prophylaxis** (Causal) is rarely achieved; most travelers use **Suppressive Prophylaxis** (starting before travel and continuing for 4 weeks after returning).

Q: Which of the following drugs is NOT used in the management of CMV retinitis?

Acyclovir. **Explanation:** The correct answer is **Acyclovir**. **1. Why Acyclovir is the correct answer:** Acyclovir is highly effective against Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV), but it has **minimal activity against Cytomegalovirus (CMV)**. This is because Acyclovir requires initial phosphorylation by a viral-specific enzyme called **Thymidine Kinase** to become active. CMV lacks this specific enzyme (it uses a protein kinase called UL97 instead), making Acyclovir ineffective for treating CMV infections like retinitis. **2. Analysis of incorrect options:** * **Ganciclovir:** This is the **drug of choice** for CMV retinitis. It is phosphorylated by the CMV-specific protein kinase **UL97**, allowing it to inhibit CMV DNA polymerase effectively. * **Foscarnet:** An inorganic pyrophosphate analog that directly inhibits viral DNA polymerase without requiring activation by viral kinases. It is used as a second-line agent or when resistance to Ganciclovir occurs. * **Cidofovir:** A nucleotide analog that is already phosphorylated. It does not require viral enzymes for activation and is used for CMV retinitis, particularly in patients with Ganciclovir resistance. **3. NEET-PG High-Yield Pearls:** * **Valganciclovir:** The oral prodrug of Ganciclovir; it is the preferred agent for induction and maintenance therapy of CMV retinitis due to its high oral bioavailability. * **Major Side Effects:** * **Ganciclovir:** Bone marrow suppression (Neutropenia). * **Foscarnet/Cidofovir:** Nephrotoxicity. * **Cidofovir Administration:** Must be given with **Probenecid** and aggressive hydration to reduce nephrotoxicity. * **Letermovir:** A newer drug that inhibits the CMV DNA terminase complex, used for prophylaxis in transplant recipients.

Question 1

All are features of ethambutol toxicity, except?

Accepted Answer

Hypercalcemia

Answer

Retrobulbar neuritis

Answer

Colour vision defects

Answer

Hyperuricemia

Question 2

Orange coloured urine is a known side effect of which of the following drugs?

Accepted Answer

Rifampicin

Answer

Isoniazid (INH)

Answer

Pyrazinamide

Answer

Ethambutol

Question 3

What is the drug of choice for the treatment of malaria due to P. vivax in a 25-year-old pregnant female?

Accepted Answer

Chloroquine

Answer

Primaquine

Answer

Sulfadoxine-pyrimethamine

Answer

Quinine

Question 4

What drug is used in the treatment of resistant gonorrhea?

Accepted Answer

Spectinomycin

Answer

Penicillin

Answer

Cotrimoxazole

Answer

Erythromycin

Question 5

Anterior nares is the most common site of colonization in the carrier state of MRSA. What is the best treatment?

Accepted Answer

Topical mupirocin

Answer

Oral Vancomycin

Answer

Inhaled colistin

Answer

IV cefazolin

Question 6

Sulfonamides inhibit bacterial synthesis of folic acid by:

Accepted Answer

Competitive inhibition.

Answer

Uncompetitive inhibition.

Answer

Allosteric inhibition.

Answer

Non-competitive inhibition.

Question 7

All of the following drugs are contraindicated in patients with G-6-PD deficiency, except?

Accepted Answer

Ceftriaxone

Answer

Cotrimoxazole

Answer

Furazolidone

Answer

Nalidixic acid

Question 8

Which of the following cephalosporins can cause thrombocytopenia?

Accepted Answer

Ceftriaxone

Answer

Cefazolin

Answer

Cefamandole

Answer

Ceftabiprole

Question 9

If a drug is active against the pre-erythrocytic stage of the malaria parasite, it will be useful as:

Accepted Answer

Causal prophylactic

Answer

Suppressive prophylactic

Answer

Clinical curative

Answer

Radical curative

Question 10

Which of the following drugs is NOT used in the management of CMV retinitis?

Accepted Answer

Acyclovir

Answer

Foscarnet

Answer

Ganciclovir

Answer

Cidofovir

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?